| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $27K | +2.2% |
| Operating Income | -$2.9M | -68.0% |
| Income Tax | $0 | — |
| Net Income | -$4.4M | -5.5% |
| EPS (Basic) | -$10.46 | -5.4% |
| EPS (Diluted) | -$10.46 | -5.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.1M | -13.0% |
| Current Assets | $20.1M | -12.9% |
| Total Assets | $25.1M | -10.6% |
| Current Liabilities | $494K | -15.2% |
| Total Liabilities | $44.8M | +3.3% |
| Stockholders' Equity | -$19.7M | -29.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.0M | -55.5% |
| Financing Cash Flow | $0 | — |